Lenalidomide-associated progressive multifocal leukoencephalopathy

Leuk Lymphoma. 2017 Oct;58(10):2514-2515. doi: 10.1080/10428194.2017.1292355. Epub 2017 Feb 21.

Authors

Francesco Brigo^{1

2}, Elisabetta Pagani³, Frediano Tezzon², Elisa Masi³, Raffaele Nardone^{2

4}

Affiliations

¹ a Department of Neuroscience, Biomedicine and Movement , University of Verona , Verona , Italy.
² b Division of Neurology , Franz Tappeiner Hospital , Merano , Italy.
³ c Laboratorio Aziendale di Microbiologia e Virologia , Comprensorio Sanitario di Bolzano , Bolzano , Italy.
⁴ d Department of Neurology , Christian Doppler Medical Centre, Paracelsus Medical University , Salzburg , Austria.

PMID: 28278713
DOI: 10.1080/10428194.2017.1292355

No abstract available

Publication types

Case Reports

MeSH terms

Humans
Lenalidomide / adverse effects*
Leukoencephalopathy, Progressive Multifocal / chemically induced*
Leukoencephalopathy, Progressive Multifocal / pathology*
Middle Aged
Multiple Myeloma / drug therapy*
Multiple Myeloma / pathology
Prognosis

Substances

Lenalidomide